Patent details
EP1663247 Title: USE OF OXCARBAZEPINE FOR THE IMPROVEMENT OF SLEEP IN PATIENTS SUFFERING FROM CHRONIC PAIN
Basic Information
- Publication number:
- EP1663247
- PCT Application Number:
- PCT/EP/2004/009797
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047647557
- PCT Publication Number:
- WO/2005/020968
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF OXCARBAZEPINE FOR THE IMPROVEMENT OF SLEEP IN PATIENTS SUFFERING FROM CHRONIC PAIN
- French Title of Invention:
- UTILISATION D'OXCARBAZEPINE DANS L'AMELIORATION DU SOMMEIL CHEZ DES PATIENTS SOUFFRANT DE LA DOULEUR CHRONIQUE
- German Title of Invention:
- VERWENDUNG VON OXCARBAZEPIN ZUR VERBESSERUNG DES SCHLAFES BEI PATIENTEN DIE AN CHRONISCHEM SCHMERZ LEIDEN
- SPC Number:
Dates
- Filing date:
- 02/09/2004
- Grant date:
- 28/10/2009
- EP Publication Date:
- 28/10/2009
- PCT Publication Date:
- 10/03/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2006
- EP B1 Publication Date:
- 28/10/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/09/2010
- Expiration date:
- 02/09/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/09/2004
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
- Name:
- MANNING Donald
- Address:
- United States (US)
Priority
1
- Priority Number:
- 0320637
- Priority Date:
- 03/09/2003
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 537378 P
- Priority Date:
- 16/01/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/55;
| Filing date | Document type | Number of pages |
|---|